Use of antithrombin III in critical patients
- 1 November 1994
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 20 (8), 577-580
- https://doi.org/10.1007/bf01705725
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution*European Journal of Haematology, 1989
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockThe New England Journal of Medicine, 1987
- Clinical Evaluation of Antithrombin III Concentrate (BI 6.013) for Disseminated Intravascular Coagulation in ObstetricsGynecologic and Obstetric Investigation, 1987
- Human Antithrombin Concentrates and Experimental Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 1985
- APACHE IICritical Care Medicine, 1985
- Plasma Fibronectin and Associated Variables in Surgical Intensive Care PatientsAnnals of Surgery, 1983
- Clinical Relevance of Antithrombin IIISeminars in Thrombosis and Hemostasis, 1982
- Disseminated Intravascular Coagulation, Antithrombin III, and Complement in Meningococcal InfectionsActa Medica Scandinavica, 1981
- Effect of Human Granulocytic Elastase on Isolated Human Antithrombin IIIHoppe-Seyler´s Zeitschrift für physiologische Chemie, 1981
- Antithrombin III: Protection against Death after Injection of ThromboplastinScience, 1969